The total return over the past 12 months is +87.93% vs. +16.94% for the S&P 500. So far it's up +62.52% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | +87.93% | +58.45% | +9.26% | (17.43%) | N/A | N/A |
| Total Return CAGR | +87.93% | +58.45% | +9.26% | (17.43%) | N/A | N/A |
| Revenue CAGR | (2.86%) | +0.16% | +0.29% | N/A | N/A | N/A |
| Net Income CAGR | (44.86%) | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | (45.29%) | +211.99% | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | (7.09%) | +53.70% | +90.51% | N/A | N/A | N/A |
| Operating Cash Flow CAGR | (7.20%) | +10.04% | +28.66% | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Puma Biotechnology, Inc. (PBYI)
| Year | Start price | End price | PBYI Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $5.95 | $9.67 | +62.52% | +14.51% | +48.01% |
| 2025 | $3.05 | $5.95 | +95.08% | +17.72% | +77.36% |
| 2024 | $4.33 | $3.05 | (29.56%) | +24.89% | (54.45%) |
| 2023 | $4.23 | $4.33 | +2.36% | +26.19% | (23.83%) |
| 2022 | $3.04 | $4.23 | +39.14% | (18.17%) | +57.31% |
| 2021 | $10.26 | $3.04 | (70.37%) | +28.74% | (99.11%) |
| 2020 | $8.75 | $10.26 | +17.26% | +18.37% | (1.11%) |
| 2019 | $20.35 | $8.75 | (57.00%) | +31.22% | (88.22%) |
| 2018 | $98.85 | $20.35 | (79.41%) | (4.56%) | (74.85%) |
| 2017 | $30.70 | $98.85 | +221.99% | +21.70% | +200.29% |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
